Publications by Leiv Ose
243 publications found
Original articles
Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study
Front Pharmacol, 11, 560958
DOI 10.3389/fphar.2020.560958, PubMed 33737874
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
Heart, 104 (19), 1600-1607
DOI 10.1136/heartjnl-2017-312706, PubMed 29622598
Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013
Eur J Prev Cardiol, 24 (2), 137-144
DOI 10.1177/2047487316676135, PubMed 27794106
Cardiovascular disease in patients with genotyped familial hypercholesterolemia in Norway during 1994-2009, a registry study
Eur J Prev Cardiol, 23 (18), 1962-1969
DOI 10.1177/2047487316666371, PubMed 27558979
Dietary counseling is associated with an improved lipid profile in children with familial hypercholesterolemia
Atherosclerosis, 252, 21-27
DOI 10.1016/j.atherosclerosis.2016.07.913, PubMed 27494447
Maternal inheritance does not predict cholesterol levels in children with familial hypercholesterolemia
Atherosclerosis, 243 (1), 155-60
DOI 10.1016/j.atherosclerosis.2015.09.014, PubMed 26386212
Long-term follow-up of young adults with familial hypercholesterolemia after participation in clinical trials during childhood
J Clin Lipidol, 9 (6), 778-785
DOI 10.1016/j.jacl.2015.08.008, PubMed 26687698
Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010
J Am Heart Assoc, 3 (6), e001236
DOI 10.1161/JAHA.114.001236, PubMed 25468658
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approach
Eur J Hum Genet, 23 (3), 381-7
DOI 10.1038/ejhg.2014.101, PubMed 24916650
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment
Atherosclerosis, 233 (2), 561-567
DOI 10.1016/j.atherosclerosis.2014.01.022, PubMed 24530965
Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy
Scand J Clin Lab Invest, 74 (1), 1-7
DOI 10.3109/00365513.2013.854926, PubMed 24236948
Subjects with low plasma HDL cholesterol levels are characterized by an inflammatory and oxidative phenotype
PLoS One, 8 (11), e78241
DOI 10.1371/journal.pone.0078241, PubMed 24244297
Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
J Nutr Sci, 2, e32
DOI 10.1017/jns.2013.27, PubMed 25191582
Phytosterol capsules and serum cholesterol in hypercholesterolemia: a randomized controlled trial
Atherosclerosis, 228 (2), 421-5
DOI 10.1016/j.atherosclerosis.2013.03.001, PubMed 23623012
No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy
Scand Cardiovasc J, 47 (2), 80-7
DOI 10.3109/14017431.2012.756119, PubMed 23301875
Maternal familial hypercholesterolaemia (FH) confers altered haemostatic profile in offspring with and without FH
Thromb Res, 131 (2), 178-82
DOI 10.1016/j.thromres.2012.11.008, PubMed 23199546
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis
Cytokine, 61 (1), 194-8
DOI 10.1016/j.cyto.2012.09.016, PubMed 23131422
Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia
J Intern Med, 273 (1), 69-78
DOI 10.1111/j.1365-2796.2012.02584.x, PubMed 22891927
Cholesterol efflux mediators in homozygous familial hypercholesterolemia patients on low-density lipoprotein apheresis
J Clin Lipidol, 7 (2), 109-16
DOI 10.1016/j.jacl.2012.08.001, PubMed 23415429
Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia
J Clin Lipidol, 6 (4), 331-9
DOI 10.1016/j.jacl.2012.03.004, PubMed 22836070
[Assessment of dietary habits and life style]
Tidsskr Nor Laegeforen, 131 (5), 454
DOI 10.4045/tidsskr.10.0799, PubMed 21383795
Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia
Atherosclerosis, 216 (2), 426-32
DOI 10.1016/j.atherosclerosis.2011.02.007, PubMed 21376325
An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia
Pediatr Cardiol, 32 (4), 433-41
DOI 10.1007/s00246-011-9885-z, PubMed 21259004
Children with familial hypercholesterolemia are characterized by an inflammatory imbalance between the tumor necrosis factor α system and interleukin-10
Atherosclerosis, 214 (1), 163-8
DOI 10.1016/j.atherosclerosis.2010.10.002, PubMed 21040915
[Clinical trials--viewpoints from participants]
Tidsskr Nor Laegeforen, 130 (16), 1606-8
DOI 10.4045/tidsskr.09.0030, PubMed 20805857
HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study
Scand Cardiovasc J, 44 (4), 197-200
DOI 10.3109/14017431003624123, PubMed 20636227
Pitavastatin: a distinctive lipid-lowering drug
Clin. Lipidol., 5 (3), 309-323
DOI 10.2217/CLP.10.28
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia
Atherosclerosis, 210 (1), 202-8
DOI 10.1016/j.atherosclerosis.2009.12.009, PubMed 20080236
Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins
Br J Nutr, 102 (12), 1783-9
DOI 10.1017/S0007114509991048, PubMed 19682403
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
Curr Med Res Opin, 25 (11), 2755-64
DOI 10.1185/03007990903290886, PubMed 19785568
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial
JAMA, 301 (11), 1131-9
DOI 10.1001/jama.301.11.1131, PubMed 19293413
Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
Acta Obstet Gynecol Scand, 88 (2), 222-6
DOI 10.1080/00016340802503047, PubMed 18972234
Dysregulated RANK ligand/RANK axis in hyperhomocysteinemic subjects: effect of treatment with B-vitamins
Stroke, 40 (1), 241-7
DOI 10.1161/STROKEAHA.108.522995, PubMed 19008470
The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects
J Nutr, 138 (11), 2070-5
DOI 10.3945/jn.108.090704, PubMed 18936200
The real code of leonardo da vinci
Curr Cardiol Rev, 4 (1), 60-2
DOI 10.2174/157340308783565401, PubMed 19924278
Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening
Community Genet, 11 (1), 26-35
DOI 10.1159/000111637, PubMed 18196915
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques
Clin Ther, 29 (11), 2419-32
DOI 10.1016/j.clinthera.2007.10.004, PubMed 18158082
[Lipid profile in children and adolescents with familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 127 (18), 2363-6
PubMed 17895939
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin
Metabolism, 56 (9), 1285-92
DOI 10.1016/j.metabol.2007.05.003, PubMed 17697874
Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
J Clin Lipidol, 1 (4), 280-6
DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692
A multi-centre, randomised, double-blind 14-week extension study examining the long-term safety and efficacy profile of the ezetimibe/simvastatin combination tablet
Int J Clin Pract, 61 (9), 1469-80
DOI 10.1111/j.1742-1241.2007.01402.x, PubMed 17655686
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome
Metab Syndr Relat Disord, 5 (1), 13-21
DOI 10.1089/met.2006.0033, PubMed 18370810
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186
Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy
Clin Pharmacol Ther, 79 (6), 532-9
DOI 10.1016/j.clpt.2006.02.014, PubMed 16765141
Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects
Stroke, 37 (7), 1731-6
DOI 10.1161/01.STR.0000226465.84561.cb, PubMed 16728689
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis
Curr Med Res Opin, 22 (5), 823-35
DOI 10.1185/030079906X100131, PubMed 16709304
Triglyceride-rich HDL3 from patients with familial hypercholesterolemia are less able to inhibit cytokine release or to promote cholesterol efflux
J Nutr, 136 (4), 877-81
DOI 10.1093/jn/136.4.877, PubMed 16549444
Increased inflammatory markers in children with familial hypercholesterolaemia
Eur J Clin Invest, 36 (3), 147-52
DOI 10.1111/j.1365-2362.2006.01613.x, PubMed 16506958
Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
Atherosclerosis, 189 (2), 451-7
DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729
Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy
Arterioscler Thromb Vasc Biol, 26 (5), 1094-100
DOI 10.1161/01.ATV.0000204337.81286.1c, PubMed 16424354
Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects
Scand J Clin Lab Invest, 66 (1), 45-54
DOI 10.1080/00335510500429821, PubMed 16464786
Perceived vulnerability to heart disease in patients with familial hypercholesterolemia: a qualitative interview study
Ann Fam Med, 4 (3), 198-204
DOI 10.1370/afm.529, PubMed 16735520
Lipid management and cholesterol goal attainment in Norway
Am J Cardiovasc Drugs, 6 (2), 121-8
DOI 10.2165/00129784-200606020-00006, PubMed 16555865
Chemokines in children with heterozygous familiar hypercholesterolemia: selective upregulation of RANTES
Arterioscler Thromb Vasc Biol, 26 (1), 200-5
DOI 10.1161/01.ATV.0000193619.67288.ed, PubMed 16254204
Altered composition of HDL3 in FH subjects causing a HDL subfraction with less atheroprotective function
Clin Chim Acta, 359 (1-2), 171-8
DOI 10.1016/j.cccn.2005.03.050, PubMed 15936009
Long-term compliance and changes in plasma lipids, plant sterols and carotenoids in children and parents with FH consuming plant sterol ester-enriched spread
Eur J Clin Nutr, 58 (12), 1612-20
DOI 10.1038/sj.ejcn.1602015, PubMed 15199384
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia
Clin Ther, 26 (11), 1758-73
DOI 10.1016/j.clinthera.2004.11.016, PubMed 15639688
[A family-based strategy for diagnosing familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 124 (9), 1228-9
PubMed 15131703
Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans
J Nutr, 134 (3), 562-7
DOI 10.1093/jn/134.3.562, PubMed 14988447
Hyperhomocysteinemic subjects have enhanced expression of lectin-like oxidized LDL receptor-1 in mononuclear cells
J Nutr, 133 (11), 3588-91
DOI 10.1093/jn/133.11.3588, PubMed 14608078
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups
Clin Cardiol, 26 (11), 509-14
DOI 10.1002/clc.4960261106, PubMed 14640465
Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender
Eur Heart J, 24 (19), 1756-62
DOI 10.1016/s0195-668x(03)00467-6, PubMed 14522571
Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial
J Pediatr, 143 (1), 74-80
DOI 10.1016/S0022-3476(03)00186-0, PubMed 12915827
Expression of matrix metalloproteinase-9 in mononuclear cells of hyperhomocysteinaemic subjects
Eur J Clin Invest, 33 (7), 555-60
DOI 10.1046/j.1365-2362.2003.01189.x, PubMed 12814391
Folic acid treatment reduces elevated plasma levels of asymmetric dimethylarginine in hyperhomocysteinaemic subjects
Br J Nutr, 89 (3), 359-63
DOI 10.1079/BJN2002779, PubMed 12628031
Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia
Am Heart J, 144 (6), 1044-51
DOI 10.1067/mhj.2002.128049, PubMed 12486429
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin
Circulation, 106 (17), 2231-7
DOI 10.1161/01.cir.0000035247.42888.82, PubMed 12390953
Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia
Am J Clin Nutr, 76 (2), 338-44
DOI 10.1093/ajcn/76.2.338, PubMed 12145004
Familial hypercholesterolemia from children to adults
Cardiovasc Drugs Ther, 16 (4), 289-93
DOI 10.1023/a:1021773724477, PubMed 12652097
[Müller-Harbitz disease--familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 122 (9), 924-5
PubMed 12082837
Reproducibility and validity of a short food questionnaire for the assessment of dietary habits
Nutr Metab Cardiovasc Dis, 12 (2), 60-70
PubMed 12189905
Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects
Arterioscler Thromb Vasc Biol, 22 (4), 699-703
DOI 10.1161/01.atv.0000013288.35930.90, PubMed 11950713
Serum cholesterol response to replacing butter with a new trans-free margarine in hypercholesterolemic subjects
Nutr Metab Cardiovasc Dis, 11 (5), 320-6
PubMed 11887429
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively
Am J Hum Genet, 69 (2), 278-90
DOI 10.1086/321294, PubMed 11452359
Fine mapping of a gene responsible for regulating dietary cholesterol absorption; founder effects underlie cases of phytosterolaemia in multiple communities
Eur J Hum Genet, 9 (5), 375-84
DOI 10.1038/sj.ejhg.5200628, PubMed 11378826
Disposition of homocysteine in subjects heterozygous for homocystinuria due to cystathionine beta-synthase deficiency: relationship between genotype and phenotype
Am J Med Genet, 100 (3), 204-13
DOI 10.1002/ajmg.1247, PubMed 11343305
Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects
Am J Med, 110 (7), 536-42
DOI 10.1016/s0002-9343(01)00696-9, PubMed 11343667
[Treatment goals for blood lipids in high risk patients of atherosclerotic disease]
Tidsskr Nor Laegeforen, 121 (9), 1059-63
PubMed 11354882
Effect of Norwegian fish powder on risk factors for coronary heart disease among hypercholesterolemic individuals
Nutr Metab Cardiovasc Dis, 10 (6), 323-30
PubMed 11302007
Lipid treatment goals achieved in patients treated with statin drugs in Norwegian general practice
Am J Cardiol, 86 (11), 1250-3, A6
DOI 10.1016/s0002-9149(00)01212-1, PubMed 11090801
Does maternal or paternal heredity affect carotid atherosclerosis in children with familial hypercholesterolaemia?
Acta Paediatr, 89 (12), 1490-2
DOI 10.1080/080352500456705, PubMed 11195242
Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia
Nutr Metab Cardiovasc Dis, 10 (5), 253-62
PubMed 11213534
[The diet of patients with atherosclerotic disease compared with the standard diet in the population]
Tidsskr Nor Laegeforen, 120 (22), 2618-24
PubMed 11077504
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels
Am J Cardiol, 86 (2), 221-3
DOI 10.1016/s0002-9149(00)00942-5, PubMed 10913488
A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia
Arterioscler Thromb Vasc Biol, 20 (7), 1784-8
DOI 10.1161/01.atv.20.7.1784, PubMed 10894817
Application of simple lipid treatment goals in patients with atherosclerotic disease
Nutr Metab Cardiovasc Dis, 10 (2), 71-8
PubMed 10919171
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group
Clin Cardiol, 23 (1), 39-46
DOI 10.1002/clc.4960230108, PubMed 10680028
Cerivastatin gender effect: sub-analyses of results from a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 16 (2), 80-7
PubMed 10893651
Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I
Am J Cardiol, 83 (10), 1476-7, A7
DOI 10.1016/s0002-9149(99)00153-8, PubMed 10335764
Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia
J Intern Med, 245 (4), 337-44
DOI 10.1046/j.1365-2796.1999.00450.x, PubMed 10356595
Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene
J Lipid Res, 40 (2), 213-20
PubMed 9925649
Efficacy and safety of cerivastatin, 0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational, randomised, double-blind study. Cerivastatin Study Group
Curr Med Res Opin, 15 (3), 228-40
DOI 10.1185/03007999909114095, PubMed 10621930
Mutant transcripts of the LDL receptor gene: mRNA structure and quantity
Hum Mutat, 13 (3), 186-96
DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K, PubMed 10090473
An update on familial hypercholesterolaemia
Ann Med, 31 (sup1), 13-18
DOI 10.1080/07853890.1999.11904394, PubMed 28850282
Efficacy and safety of 300 micrograms and 400 micrograms cerivastatin once daily in patients with primary hypercholesterolaemia: a multicentre, randomized, double-blind, placebo-controlled study
J Int Med Res, 27 (3), 115-29
DOI 10.1177/030006059902700302, PubMed 10505301
Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects
Eur J Clin Invest, 28 (12), 971-9
DOI 10.1046/j.1365-2362.1998.00399.x, PubMed 9893006
Clinical efficacy and safety of cerivastatin: summary of pivotal phase IIb/III studies
Am J Cardiol, 82 (4B), 32J-39J
DOI 10.1016/s0002-9149(98)00435-4, PubMed 9737644
Efficacy and six-month safety of simvastatin 80 mg/day: Results from the worldwide simvastatin expanded dose program (WSEDP)
Nutr. Metab. Carbiovasc. Dis., 8 (3), 135-143
[Attitude to genetic screening for familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 118 (10), 1578-81
PubMed 9615587
[Referrals to the Lipid clinic--"appropriate" patients with inadequate anamnesis]
Tidsskr Nor Laegeforen, 118 (5), 749-52
PubMed 9528374
The C677T mutation in the methylenetetrahydrofolate reductase gene predisposes to hyperhomocysteinemia in children with familial hypercholesterolemia treated with cholestyramine
J Pediatr, 132 (2), 365-8
DOI 10.1016/s0022-3476(98)70465-2, PubMed 9506661
Effects of a 9.6-kb deletion of the LDL receptor gene (FH Helsinki) on structure and levels of mRNA
Hum Mutat, 12 (2), 95-102
DOI 10.1002/(SICI)1098-1004(1998)12:2<95::AID-HUMU4>3.0.CO;2-E, PubMed 9671270
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria
Hum Mol Genet, 6 (13), 2213-21
DOI 10.1093/hmg/6.13.2213, PubMed 9361025
[Diagnosis and treatment of severe hyperlipidemia]
Tidsskr Nor Laegeforen, 117 (29), 4241-4
PubMed 9441469
[What happens with patients after participation in a clinical trial?]
Tidsskr Nor Laegeforen, 117 (28), 4065-9
PubMed 9441437
Flow cytometric measurement of low density lipoprotein receptor activity validated by DNA analysis in diagnosing heterozygous familial hypercholesterolemia
Cytometry, 30 (5), 264-8
PubMed 9383100
Molecular genetics of familial hypercholesterolaemia in Norway
J Intern Med, 241 (3), 185-94
DOI 10.1046/j.1365-2796.1997.78119000.x, PubMed 9104431
[Application of gene technology in the diagnosis of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 117 (5), 678-81
PubMed 9102960
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I
J Lipid Res, 38 (1), 121-31
PubMed 9034206
Results of intensive long-term treatment of familial hypercholesterolemia
Am J Cardiol, 78 (12), 1369-74
DOI 10.1016/s0002-9149(96)00649-2, PubMed 8970408
Effect of hormone replacement therapy on the susceptibility of low-density lipoprotein to oxidation among postmenopausal hypercholesterolaemic women
Eur J Clin Invest, 26 (12), 1062-8
DOI 10.1046/j.1365-2362.1996.390593.x, PubMed 9013080
The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia
Metabolism, 45 (11), 1415-21
DOI 10.1016/s0026-0495(96)90124-9, PubMed 8931648
Colestipol tablets in adolescents with familial hypercholesterolaemia
Acta Paediatr, 85 (9), 1080-2
DOI 10.1111/j.1651-2227.1996.tb14221.x, PubMed 8888922
Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects
Arterioscler Thromb Vasc Biol, 16 (8), 984-91
DOI 10.1161/01.atv.16.8.984, PubMed 8696963
Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein
J Lipid Res, 37 (7), 1591-600
PubMed 8827529
Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
J Pediatr, 129 (1), 42-9
DOI 10.1016/s0022-3476(96)70188-9, PubMed 8757561
Relation of total homocysteine and lipid levels in children to premature cardiovascular death in male relatives
Pediatr Res, 40 (1), 47-52
DOI 10.1203/00006450-199607000-00009, PubMed 8798245
Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case
Scand J Clin Lab Invest, 56 (3), 229-40
DOI 10.3109/00365519609088612, PubMed 8761527
Low dose colestipol in adolescents with familial hypercholesterolaemia
Arch Dis Child, 74 (2), 157-60
DOI 10.1136/adc.74.2.157, PubMed 8660081
Two novel missense mutations in the LDL receptor gene causing familial hypercholesterolemia
Clin Genet, 49 (2), 85-7
DOI 10.1111/j.1399-0004.1996.tb04333.x, PubMed 8740918
[Treatment of hyperlipidemia. Guidelines for treatment of hyperlipidemia for secondary prevention of ischemic heart disease]
Tidsskr Nor Laegeforen, 115 (29), 3629-31
PubMed 8539720
[A rapid analysis of the lipid profile. A comparative study of different analytical methods for determination of blood lipids]
Tidsskr Nor Laegeforen, 115 (28), 3487-9
PubMed 7491599
[Familial hypercholesterolemia in children. A management program. Procedures for diagnosis and treatment in our pediatric departments]
Tidsskr Nor Laegeforen, 115 (28), 3514
PubMed 7491607
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition
Metabolism, 44 (11), 1447-54
DOI 10.1016/0026-0495(95)90145-0, PubMed 7476333
The detection and management of dyslipidaemia in children and adolescents
Acta Paediatr, 84 (11), 1213-5
PubMed 8580613
EFFECTIVENESS OF COLESTIPOL TABLETS VS GRANULES IN PATIENTS WITH MODERATE TO SEVERE HYPERCHOLESTEROLEMIA
Clin. Drug Invest., 10 (5), 257-263
DOI 10.2165/00044011-199510050-00002
No effect of beta-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesterolaemic, postmenopausal women
Scand J Clin Lab Invest, 55 (6), 477-85
DOI 10.3109/00365519509075385, PubMed 8571077
Double-Blind Comparison of the Efficacy and Tolerability of Simvastatin and Fluvastatin in Patients with Primary Hypercholesterolaemia
Clin Drug Investig, 10 (3), 127-38
DOI 10.2165/00044011-199510030-00001, PubMed 27519196
Standardization of a flow cytometric method for measurement of low-density lipoprotein receptor activity on blood mononuclear cells
Cytometry, 20 (4), 290-5
DOI 10.1002/cyto.990200404, PubMed 7587716
Determinants of lipid levels among children with heterozygous familial hypercholesterolemia in Norway
Arterioscler Thromb Vasc Biol, 15 (8), 1009-14
DOI 10.1161/01.atv.15.8.1009, PubMed 7627689
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group
Am J Cardiol, 76 (2), 65A-70A
DOI 10.1016/s0002-9149(05)80021-9, PubMed 7604802
CHANGES IN PLASMA APOLIPOPROTEIN B-CONTAINING LIPOPARTICLE LEVELS FOLLOWING THERAPY WITH FLUVASTATIN AND CHOLESTYRAMINE
Am. J. Cardiol., 76 (2), A65-A70
Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women
J Intern Med, 238 (1), 39-47
DOI 10.1111/j.1365-2796.1995.tb00897.x, PubMed 7608645
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 95 (6), 671-6
DOI 10.1007/BF00209485, PubMed 7789953
PHYSICAL-FITNESS AND FIBRINOGEN LEVELS AMONG HYPERCHOLESTEROLEMIC POSTMENOPAUSAL WOMEN
Nutr. Metab. Carbiovasc. Dis., 5 (2), 93-97
A novel variant of lysosomal acid lipase (Leu336-->Pro) associated with acid lipase deficiency and cholesterol ester storage disease
Arterioscler Thromb Vasc Biol, 15 (6), 773-8
DOI 10.1161/01.atv.15.6.773, PubMed 7773732
Identification of the apo B-3500 mutation in the Norwegian population
Scand J Clin Lab Invest, 55 (3), 217-21
DOI 10.3109/00365519509089616, PubMed 7638555
[Diet and lipid status in pregnant women]
Tidsskr Nor Laegeforen, 115 (11), 1358-60
PubMed 7770831
Is dietary intervention effective in post-transplant hyperlipidaemia?
Nephrol Dial Transplant, 10 (1), 82-5
PubMed 7724035
Effect of large-volume liposuction on sex hormones and glucose- and lipid metabolism in females
Aesthetic Plast Surg, 19 (2), 131-5
DOI 10.1007/BF00450248, PubMed 7598023
Familial hypercholesterolaemia caused by a non-sense mutation in codon 329 of the LDL receptor gene
Scand J Clin Lab Invest, 54 (8), 605-9
DOI 10.3109/00365519409087539, PubMed 7709162
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
Atherosclerosis, 111 (2), 175-82
DOI 10.1016/0021-9150(94)90091-4, PubMed 7718019
[A comparison between lovastatin and pravastatin--effects on lipids, sleep and quality of life in primary hyperlipidemia]
Tidsskr Nor Laegeforen, 114 (19), 2262-4
PubMed 7992293
[Diet therapy of hypercholesterolemia. Can the diet of persons who already follow a cholesterol-lowering diet be further improved by guidelines given by a clinical nutritionist?]
Tidsskr Nor Laegeforen, 114 (18), 2106-8
PubMed 7992266
[Iron status in postmenopausal women]
Tidsskr Nor Laegeforen, 114 (4), 436-8
PubMed 8009479
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine
Eur J Clin Pharmacol, 46 (5), 445-9
DOI 10.1007/BF00191909, PubMed 7957541
Modification of low density lipoprotein in relation to intake of fatty acids and antioxidants
World Rev Nutr Diet, 75, 144-8
DOI 10.1159/000423570, PubMed 7871817
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
Eur J Clin Pharmacol, 46 (5), 405-10
DOI 10.1007/BF00191901, PubMed 7957533
Evaluation of running conditions for SSCP analysis: application of SSCP for detection of point mutations in the LDL receptor gene
PCR Methods Appl, 3 (3), 159-62
DOI 10.1101/gr.3.3.159, PubMed 8118396
Haplotype analysis at the low density lipoprotein receptor locus in normal and familial hypercholesterolemia Norwegian subjects
Clin Genet, 44 (4), 214-20
DOI 10.1111/j.1399-0004.1993.tb03883.x, PubMed 7903228
Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia
Scand J Clin Lab Invest, 53 (5), 457-63
DOI 10.1080/00365519309092540, PubMed 8210967
Short report on DNA marker at candidate locus
Clin Genet, 44 (2), 111
PubMed 8275559
Screening for point mutations in exon 10 of the low density lipoprotein receptor gene by analysis of single-strand conformation polymorphisms: detection of a nonsense mutation-FH469-->Stop
Hum Genet, 92 (1), 6-10
DOI 10.1007/BF00216137, PubMed 8103503
A MULTICENTER COMPARATIVE TRIAL OF LOVASTATIN AND PRAVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
Am. J. Cardiol., 71 (10), 810-815
[Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III]
Tidsskr Nor Laegeforen, 113 (7), 853-6
PubMed 8480294
A 9.6 kilobase deletion in the low density lipoprotein receptor gene in Norwegian familial hypercholesterolemia subjects
Clin Genet, 42 (6), 288-95
DOI 10.1111/j.1399-0004.1992.tb03258.x, PubMed 1362925
[Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study]
Tidsskr Nor Laegeforen, 112 (29), 3665-9
PubMed 1471127
A new polymorphism in exon 11 of the LDL receptor gene in healthy people and in familial hypercholesterolemia subjects
Clin Genet, 42 (5), 224-8
DOI 10.1111/j.1399-0004.1992.tb03245.x, PubMed 1486698
[Quality assurance in clinical trials. Problems related to patient information]
Tidsskr Nor Laegeforen, 112 (25), 3204-7
PubMed 1462295
[Familial hypercholesterolemia--intensive diet therapy combined with drug therapy]
Tidsskr Nor Laegeforen, 112 (20), 2642-6
PubMed 1412289
Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo
Eur J Clin Invest, 22 (4), 229-34
DOI 10.1111/j.1365-2362.1992.tb01456.x, PubMed 1499639
Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia
Eur J Clin Pharmacol, 42 (1), 61-4
DOI 10.1007/BF00314921, PubMed 1541317
[Treatment of hypercholesterolemia in adults. A treatment program 1991]
Tidsskr Nor Laegeforen, 111 (28), 3407-11
PubMed 1792668
Dietary n-6 fatty acids inhibit the incorporation of dietary n-3 fatty acids in thrombocyte and serum phospholipids in humans: a controlled dietetic study
Scand J Clin Lab Invest, 51 (3), 255-63
DOI 10.3109/00365519109091612, PubMed 1909049
Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system
Arterioscler Thromb, 11 (1), 138-45
DOI 10.1161/01.atv.11.1.138, PubMed 1987991
[Identification of syndromes using a combined computer and video program]
Tidsskr Nor Laegeforen, 110 (9), 1085-7
PubMed 2184540
[Are prosecuted parents allowed the benefit of the doubt in cases of child abuse?]
Tidsskr Nor Laegeforen, 110 (5), 627-8
PubMed 2309218
[Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]
Tidsskr Nor Laegeforen, 109 (7-8), 850-2
PubMed 2705170
Dietary n-3 fatty acids and children with hyperlipidaemia
J Intern Med Suppl, 731, 181-3
DOI 10.1111/j.1365-2796.1989.tb01453.x, PubMed 2706040
Computed tomography of a tuberculous paravertebral abscess
Z Kinderchir, 43 (6), 430-2
DOI 10.1055/s-2008-1044106, PubMed 3239258
[Fraser's syndrome--cryptophthalmia]
Tidsskr Nor Laegeforen, 108 (25), 1998-9
PubMed 3144053
[Cardiovascular diseases: we start with children]
Nord Med, 102 (10), 265-6
PubMed 3697042
Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes
Am J Med Genet, 15 (1), 29-38
DOI 10.1002/ajmg.1320150104, PubMed 6407320
The binding of high density lipoproteins to isolated rat hepatocytes
Scand J Clin Lab Invest, 41 (1), 63-73
DOI 10.3109/00365518109092016, PubMed 7256194
Intracellular degradation of 125I-labelled asialo-glycoproteins in rat hepatocytes: effect of leupeptin on subcellular distribution of asialo-fetuin
Int J Biochem, 13 (3), 253-9
DOI 10.1016/0020-711x(81)90076-8, PubMed 6163669
Binding, uptake, and degradation of 125I-labelled high-density lipoproteins in isolated non-parenchymal rat liver cells
Scand J Gastroenterol, 16 (1), 71-80
PubMed 7233082
Catabolism of (125-I)low density lipoproteins in isolated rat liver cells
Biochem Biophys Res Commun, 97 (1), 192-9
DOI 10.1016/s0006-291x(80)80153-7, PubMed 7458932
The effect of ammonia, chloroquine, leupeptin, colchicine and cytochalasin B on degradation of high density lipoproteins in isolated rat hepatocytes
Exp Cell Res, 130 (1), 127-35
DOI 10.1016/0014-4827(80)90049-x, PubMed 7192635
The intracellular distribution of high density lipoproteins taken up by isolated rat hepatocytes
Biochim Biophys Acta, 620 (1), 120-32
DOI 10.1016/0005-2760(80)90191-5, PubMed 6251895
Fluid endocytosis in isolated rat parenchymal and non-parenchymal liver cells
Exp Cell Res, 126 (1), 109-19
DOI 10.1016/0014-4827(80)90475-9, PubMed 7188905
Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro
Biochim Biophys Acta, 574 (3), 521-36
DOI 10.1016/0005-2760(79)90248-0, PubMed 226159
Hyperlipidemia: clinical clues in the first two decades of life
Johns Hopkins Med J, 140 (4), 171-6
PubMed 850334
[Hyperlipemia in children]
Tidsskr Nor Laegeforen, 97 (2), 67-73
PubMed 835105
Prophylactiv use of propranolol in the Marfan syndrome to prevent aortic dissection
Birth Defects Orig Artic Ser, 13 (3C), 163-9
PubMed 19114
A heritable syndrome of craniosynostosis, short thin hair, dental abnormalities, and short limbs: cranioectodermal dysplasia
J Pediatr, 90 (1), 55-61
DOI 10.1016/s0022-3476(77)80764-6, PubMed 830894
Neonatal osteomyelitis caused by group B streptococci
Scand J Infect Dis, 8 (3), 219-21
DOI 10.3109/inf.1976.8.issue-3.20, PubMed 788147
Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated with coronary heart disease
Scand J Clin Lab Invest, 36 (1), 75-9
DOI 10.1080/00365517609068021, PubMed 176718
Letter: L.D.L. and total cholesterol in cord-blood screening for familial hypercholesterolaemia
Lancet, 2 (7935), 615-6
DOI 10.1016/s0140-6736(75)90216-0, PubMed 51449
[Finnish families in the town of Sør-Varanger. II. A study of blood pressure, height, weight, cholesterol, triglycerides and lipoprotein electrophoresis among Finnish men - combined effects of a change in diet]
Sykepleien, 62 (16), 728-35
PubMed 1043245
[Encephalitis associated with mycoplasma pneumoniae infection in children]
Tidsskr Nor Laegeforen, 95 (12), 756-8,779
PubMed 1145545
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), 88-92
PubMed 1221382
Neonatal screening for hyperlipidaemia
Postgrad Med J, 51 (8), suppl 88-92
PubMed 215987
[Routine methods for fibrinogen determination]
Tidsskr Nor Laegeforen, 94 (30), 2085-7
PubMed 4214421
[Finnish descendants in the municipality of Sor-Varanger--II. An investigation of blood pressure, height, weight, cholesterol, triglycerides and lipoproteins among Finnish descendant men--and the effect of a diet change]
Tidsskr Nor Laegeforen, 94 (26), 1565-72
PubMed 4422489
[The D-xylose-tolerance test as screeningtest for malabsorption diseases in children]
Tidsskr Nor Laegeforen, 94 (18), 1192-5
PubMed 4839995
[D-xylose tolerance in malabsorption. Method of determination of D-xylose in serum and urine]
Tidsskr Nor Laegeforen, 93 (28), 2103-5
PubMed 4773981
Review articles
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action
JAMA Cardiol, 5 (2), 217-229
DOI 10.1001/jamacardio.2019.5173, PubMed 31895433
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
Eur Heart J, 36 (36), 2425-37
DOI 10.1093/eurheartj/ehv157, PubMed 26009596
Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review
Atherosclerosis, 235 (2), 299-309
DOI 10.1016/j.atherosclerosis.2014.05.917, PubMed 24908240
Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
Expert Rev Cardiovasc Ther, 11 (8), 1061-6
DOI 10.1586/14779072.2013.814851, PubMed 23984929
Paediatric screening for hypercholesterolaemia in Europe
Arch Dis Child, 97 (3), 272-6
DOI 10.1136/archdischild-2011-300081, PubMed 21949015
Pitavastatin: finding its place in therapy
Ther Adv Chronic Dis, 2 (2), 101-17
DOI 10.1177/2040622310389227, PubMed 23251745
Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children
Semin Vasc Med, 4 (1), 51-7
DOI 10.1055/s-2004-822986, PubMed 15199433
[Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2287-8
PubMed 12448270
[Guidelines for pharmacological primary prevention of cardiovascular diseases--who should be treated?]
Tidsskr Nor Laegeforen, 122 (23), 2277-81
PubMed 12448268
[Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?]
Tidsskr Nor Laegeforen, 122 (23), 2283-6
PubMed 12448269
An update on familial hypercholesterolaemia
Ann Med, 31 Suppl 1, 13-8
PubMed 10342495
[Is there a need for genetic/molecular diagnosis of familial hypercholesterolemia?]
Tidsskr Nor Laegeforen, 117 (5), 681-3
PubMed 9102961
[Diagnosis and treatment of familial hypercholesterolemia in children and adolescents]
Tidsskr Nor Laegeforen, 115 (28), 3499-503
PubMed 7491603
[Triglycerides, HDL and coronary disease. Consensus conference: National Institutes of Health 1992]
Tidsskr Nor Laegeforen, 112 (21), 2768-71
PubMed 1412312
[Treatment of familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 107 (32), 2836-8, 2840
PubMed 3321550
Other articles
[Increased mortality in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 135 (11), 1024-5
DOI 10.4045/tidsskr.15.0244, PubMed 26080775
LDL-apheresis affects markers of endothelial function in patients with homozygous familial hypercholesterolemia
Thromb Res, 130 (5), 823-5
DOI 10.1016/j.thromres.2012.06.004, PubMed 22728023
Long-term treatment with pitavastatin is effective and well tolerated by patients with primary hypercholesterolemia or combined dyslipidemia (vol 210, pg 202, 2010)
Atherosclerosis, 212 (2), 704
DOI 10.1016/j.atherosclerosis.2010.05.023
Enhanced platelet activation in hyperhomocysteinemic individuals
J Thromb Haemost, 5 (1), 193-5
DOI 10.1111/j.1538-7836.2006.02275.x, PubMed 17059422
Psychological factors and cardiovascular disease
J Thromb Haemost, 2 (1), 201-3
DOI 10.1111/j.1538-7836.2004.0562g.x, PubMed 14717990
[Shortcomings and strength of practice guidelines]
Tidsskr Nor Laegeforen, 123 (11), 1566-7
PubMed 12822025
[Genetic screening and treatment in familial hypercholesterolemia]
Tidsskr Nor Laegeforen, 121 (13), 1635-6
PubMed 11446055
[Familial hypercholesterolemia--prognosis and treatment]
Tidsskr Nor Laegeforen, 121 (13), 1635
PubMed 11446054
Simvastatin-fluvastatin comparative study - Continued - Reply
Clin. Drug Invest., 12 (1), 57
Simvastatin-fluvastatin comparative study - Reply
Clin. Drug Invest., 11 (6), 363-364
Screening for known mutations in the LDL receptor gene causing familial hypercholesterolemia (vol 95, pg 671, 1995)
Hum. Genet., 97 (2), 268
DOI 10.1007/BF02265281
A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects
Hum Mutat, 7 (1), 70-1
DOI 10.1002/(SICI)1098-1004(1996)7:1<70::AID-HUMU12>3.0.CO;2-P, PubMed 8664907
Erratum to Double-blind comparison of the efficacy and tolerability of simvastatin and fluvastatin in patients with primary hypercholesterolaemia
Clin Drug Investig, 10 (6), 343
DOI 10.1007/BF03259374, PubMed 27519335
Screening for familial hypercholesterolaemia in relatives
Lancet, 346 (8987), 1438
DOI 10.1016/s0140-6736(95)92461-2, PubMed 7475864
FIRST ANNUAL COPENHAGEN ATHEROSCLEROSIS CONFERENCE
Arterioscl. Thromb. Vasc. Biol., 15 (10), 1787-1790
Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia
Hum Genet, 96 (2), 241-2
DOI 10.1007/BF00207391, PubMed 7635482
RESPONSIVENESS TO DIETARY INDULGENCE AMONG PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Nutr. Metab. Carbiovasc. Dis., 4 (3), 159-162
MSPL RFLP IN EXON 18 OF THE LDL RECEPTOR GENE DETECTABLE BY PCR
Clin. Genet., 44 (2), 111
[Marketing of Carduran]
Tidsskr Nor Laegeforen, 109 (17-18), 1920-1
PubMed 2526393
Familial hypercholesterolemia. 50 years of research
Arteriosclerosis, 9 (1 Suppl), I1-2
PubMed 2643426
Letter: Usefulness of the xylose test for coeliac disease
Arch Dis Child, 51 (5), 400-1
DOI 10.1136/adc.51.5.400, PubMed 938086
Circulating dopamine-beta-hydroxylase (DbetaH) and catecholamines in a paediatric phaeochromocytoma
Clin Exp Pharmacol Physiol, 3 (5), 487-91
DOI 10.1111/j.1440-1681.1976.tb00627.x, PubMed 975634
LDL AND TOTAL CHOLESTEROL IN CORD-BLOOD SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA
Lancet, 2 (7935), 615-616
Books
Familiær hyperkolesterolæmi
[S.l.] : Genzyme
BIBSYS 101621493
Sunne kaker
Damm, [Oslo], 127 s.
BIBSYS 071410058, ISBN 978-82-04-13869-9
Godt for ganen, godt for hjertet: maten som gir deg et bedre liv
Cappelen, Oslo (3. utg.), 175 s.
BIBSYS 050189530, ISBN 82-02-24399-8
Godt for ganen, godt for hjertet: sunn mat, også for deg med høyt kolesterol
Cappelen, Oslo (2. utg.), 167 s.
BIBSYS 020141122, ISBN 82-02-21424-6
Godt for ganen, godt for hjertet: sunn mat, også for deg med høyt kolesterol
Grøndahl Dreyer, Oslo, 167 s.
BIBSYS 991519612, ISBN 82-504-2553-7
Familiær hyperkolesterolemi: et orienteringshefte for helsepersonell og pasienter med familiær hyperkolesterolemi
Lipidklinikken, Rikshospitalet, Oslo ([Ny utg.]), 15 s.
BIBSYS 960697829
Familiær hyperkolesterolemi: et orienteringshefte for helsepersonell og pasienter med familiær hyperkolesterolemi
Lipidklinikken, Rikshospitalet, Oslo, 15 s.
BIBSYS 932233538
Studies on the lipoprotein catabolism in isolated rat liver cells
Institute for Nutrition Research, University of Oslo, Oslo, Fl. pag.
BIBSYS 812106342
Book chapters
Diabetes og lipidforstyrrelse
In Diabeteshåndboken, Gyldendal akademisk, Oslo, s. 270-275
BIBSYS 041965299